Cumberland Pharmaceuticals Inc.
CPIX
$2.75
-$0.05-1.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.26% | -162.02% | -158.92% | 166.03% | -23.30% |
| Total Depreciation and Amortization | 0.31% | 0.30% | 0.17% | -26.09% | 27.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,468.57% | -141.18% | -95.68% | 149.36% | 44.04% |
| Change in Net Operating Assets | -103.75% | 214.67% | -77.22% | -53.50% | 82.25% |
| Cash from Operations | -98.40% | -77.81% | -78.36% | 104.69% | 300.55% |
| Capital Expenditure | 100.00% | 10.19% | 44.33% | -1,969.57% | 85.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -360.76% | -313.51% | 126.46% | -4,718.78% | -111.95% |
| Cash from Investing | -344.89% | -341.62% | 123.28% | -4,482.84% | -114.14% |
| Total Debt Issued | -- | -- | -- | -- | -49.95% |
| Total Debt Repaid | -- | -- | 100.00% | -58.90% | 42.53% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | 100.00% | -44.44% | 97.07% | -149.90% | 0.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -81.11% | -162.12% | 71.90% | -10.01% | -6.07% |
| Cash from Financing | -76.20% | -156.56% | 97.27% | -300.91% | -156.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -321.35% | -190.97% | 134.28% | -671.85% | 289.24% |